<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="574" height="447" viewBox="0 0 574 447"><rect width="574" height="447" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(64,87)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h500v300h-500Z" stroke="lightgray" stroke-width="0.5"/><g><g class="mark-group role-axis" aria-hidden="true"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-grid" pointer-events="none"><line transform="translate(0,300)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,257)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,214)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,171)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,129)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,86)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,43)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis for a discrete scale with 13 values: 0, 1, 2, 3, 4, ending with 12"><g transform="translate(0.5,300.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(19,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(57,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(96,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(134,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(173,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(211,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(250,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(288,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(326,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(365,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(403,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(442,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(480,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(18.73076923076924,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(57.1923076923077,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">1</text><text text-anchor="end" transform="translate(95.65384615384616,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">2</text><text text-anchor="end" transform="translate(134.11538461538464,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">3</text><text text-anchor="end" transform="translate(172.5769230769231,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">4</text><text text-anchor="end" transform="translate(211.03846153846155,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">5</text><text text-anchor="end" transform="translate(249.5,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">6</text><text text-anchor="end" transform="translate(287.9615384615385,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">7</text><text text-anchor="end" transform="translate(326.42307692307696,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">8</text><text text-anchor="end" transform="translate(364.8846153846154,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">9</text><text text-anchor="end" transform="translate(403.34615384615387,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">10</text><text text-anchor="end" transform="translate(441.8076923076923,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">11</text><text text-anchor="end" transform="translate(480.2692307692308,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">12</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="500" y2="0" stroke="black" stroke-width="0.5" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Number of Participants' for a linear scale with values from 0 to 350"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,300)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,257)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,214)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,171)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,129)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,86)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,43)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,303)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(-7,260.14285714285717)" font-family="Arial" font-size="11px" fill="black" opacity="1">50</text><text text-anchor="end" transform="translate(-7,217.28571428571428)" font-family="Arial" font-size="11px" fill="black" opacity="1">100</text><text text-anchor="end" transform="translate(-7,174.42857142857142)" font-family="Arial" font-size="11px" fill="black" opacity="1">150</text><text text-anchor="end" transform="translate(-7,131.57142857142858)" font-family="Arial" font-size="11px" fill="black" opacity="1">200</text><text text-anchor="end" transform="translate(-7,88.71428571428571)" font-family="Arial" font-size="11px" fill="black" opacity="1">250</text><text text-anchor="end" transform="translate(-7,45.85714285714287)" font-family="Arial" font-size="11px" fill="black" opacity="1">300</text><text text-anchor="end" transform="translate(-7,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">350</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,300)" x2="0" y2="-300" stroke="black" stroke-width="0.5" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-40.35302734375,150) rotate(-90) translate(0,-3)" font-family="Arial" font-size="12px" font-weight="bold" fill="black" opacity="1">Number of Participants</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-rect role-mark layer_0_marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="Stage: 0; Number of Participants: 133; Diagnosis: CN; Count: 133; Percentage: 43.8%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,186h34.61538461538461v114h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 0; Number of Participants: 115; Diagnosis: EMCI; Count: 115; Percentage: 37.8%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,87.42857142857144h34.61538461538461v98.57142857142856h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 0; Number of Participants: 56; Diagnosis: LMCI; Count: 56; Percentage: 18.4%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,39.42857142857144h34.61538461538461v48.00000000000001h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 0; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 1; Number of Participants: 2; Diagnosis: CN; Count: 2; Percentage: 25.0%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,298.2857142857143h34.61538461538461v1.7142857142857224h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 1; Number of Participants: 2; Diagnosis: EMCI; Count: 2; Percentage: 25.0%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,296.57142857142856h34.61538461538461v1.7142857142857224h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 1; Number of Participants: 4; Diagnosis: LMCI; Count: 4; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,293.1428571428571h34.61538461538461v3.428571428571445h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 2; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 2; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,300h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 2; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,300h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 2; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 3; Number of Participants: 4; Diagnosis: CN; Count: 4; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,296.57142857142856h34.61538461538461v3.428571428571445h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 3; Number of Participants: 4; Diagnosis: EMCI; Count: 4; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,293.1428571428571h34.61538461538461v3.428571428571445h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 3; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,293.1428571428571h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 3; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 4; Number of Participants: 11; Diagnosis: CN; Count: 11; Percentage: 20.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,290.57142857142856h34.61538461538461v9.428571428571445h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 4; Number of Participants: 20; Diagnosis: EMCI; Count: 20; Percentage: 36.4%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,273.42857142857144h34.61538461538461v17.14285714285711h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 4; Number of Participants: 24; Diagnosis: LMCI; Count: 24; Percentage: 43.6%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,252.85714285714286h34.61538461538461v20.571428571428584h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 4; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 5; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,299.1428571428571h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 5; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 37.5%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,296.57142857142856h34.61538461538461v2.571428571428555h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 5; Number of Participants: 4; Diagnosis: LMCI; Count: 4; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,293.1428571428571h34.61538461538461v3.428571428571445h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 5; Number of Participants: 1; Diagnosis: AD; Count: 1; Percentage: 12.5%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,299.1428571428571h34.61538461538461v0.8571428571428896h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 6; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 6; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 6; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 6; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 7; Number of Participants: 2; Diagnosis: CN; Count: 2; Percentage: 4.1%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,286.2857142857143h34.61538461538461v1.7142857142857224h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 7; Number of Participants: 14; Diagnosis: EMCI; Count: 14; Percentage: 28.6%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,274.2857142857143h34.61538461538461v12h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 7; Number of Participants: 19; Diagnosis: LMCI; Count: 19; Percentage: 38.8%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,258h34.61538461538461v16.285714285714278h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 7; Number of Participants: 14; Diagnosis: AD; Count: 14; Percentage: 28.6%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,288h34.61538461538461v12h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 8; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 8; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,300h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 8; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,300h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 8; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 9; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,288h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 9; Number of Participants: 8; Diagnosis: EMCI; Count: 8; Percentage: 23.5%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,281.14285714285717h34.61538461538461v6.857142857142833h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 9; Number of Participants: 12; Diagnosis: LMCI; Count: 12; Percentage: 35.3%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,270.85714285714283h34.61538461538461v10.285714285714334h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 9; Number of Participants: 14; Diagnosis: AD; Count: 14; Percentage: 41.2%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,288h34.61538461538461v12h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 11; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M425,299.1428571428571h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 11; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M425,299.1428571428571h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 11; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M425,299.1428571428571h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 11; Number of Participants: 1; Diagnosis: AD; Count: 1; Percentage: 100.0%" role="graphics-symbol" aria-roledescription="bar" d="M425,299.1428571428571h34.61538461538461v0.8571428571428896h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 12; Number of Participants: 3; Diagnosis: CN; Count: 3; Percentage: 1.2%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,192h34.61538461538461v2.5714285714285836h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 12; Number of Participants: 16; Diagnosis: EMCI; Count: 16; Percentage: 6.2%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,178.28571428571428h34.61538461538461v13.714285714285722h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 12; Number of Participants: 117; Diagnosis: LMCI; Count: 117; Percentage: 45.2%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,78h34.61538461538461v100.28571428571428h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 12; Number of Participants: 123; Diagnosis: AD; Count: 123; Percentage: 47.5%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,194.57142857142858h34.61538461538461v105.42857142857142h-34.61538461538461Z" fill="#EE6677"/></g><g class="mark-text role-mark layer_1_marks" role="graphics-object" aria-roledescription="text mark container"><text aria-label="Stage: 0; Total: 304; Total Sample Size: 304" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">304</text><text aria-label="Stage: 0; Total: 304; Total Sample Size: 304" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">304</text><text aria-label="Stage: 0; Total: 304; Total Sample Size: 304" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">304</text><text aria-label="Stage: 0; Total: 304; Total Sample Size: 304" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">304</text><text aria-label="Stage: 1; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 1; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 1; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 1; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 2; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 2; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 2; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 2; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 3; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 3; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 3; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 3; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 4; Total: 55; Total Sample Size: 55" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">55</text><text aria-label="Stage: 4; Total: 55; Total Sample Size: 55" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">55</text><text aria-label="Stage: 4; Total: 55; Total Sample Size: 55" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">55</text><text aria-label="Stage: 4; Total: 55; Total Sample Size: 55" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">55</text><text aria-label="Stage: 5; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 5; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 5; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 5; Total: 8; Total Sample Size: 8" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">8</text><text aria-label="Stage: 6; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 6; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 6; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 6; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 7; Total: 49; Total Sample Size: 49" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">49</text><text aria-label="Stage: 7; Total: 49; Total Sample Size: 49" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">49</text><text aria-label="Stage: 7; Total: 49; Total Sample Size: 49" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">49</text><text aria-label="Stage: 7; Total: 49; Total Sample Size: 49" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">49</text><text aria-label="Stage: 8; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 8; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 8; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 8; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 9; Total: 34; Total Sample Size: 34" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">34</text><text aria-label="Stage: 9; Total: 34; Total Sample Size: 34" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">34</text><text aria-label="Stage: 9; Total: 34; Total Sample Size: 34" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">34</text><text aria-label="Stage: 9; Total: 34; Total Sample Size: 34" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">34</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 10; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 11; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 11; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 11; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 11; Total: 1; Total Sample Size: 1" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">1</text><text aria-label="Stage: 12; Total: 259; Total Sample Size: 259" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">259</text><text aria-label="Stage: 12; Total: 259; Total Sample Size: 259" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">259</text><text aria-label="Stage: 12; Total: 259; Total Sample Size: 259" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">259</text><text aria-label="Stage: 12; Total: 259; Total Sample Size: 259" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">259</text></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend for fill color with 4 values: CN, EMCI, LMCI, AD"><g transform="translate(0,-29)"><path class="background" aria-hidden="true" d="M0,0h181v11h-181Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h31.8876953125v11h-31.8876953125Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#4477AA" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">CN</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(42,0)"><path class="background" aria-hidden="true" d="M0,0h43.5v11h-43.5Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#66CCEE" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">EMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(96,0)"><path class="background" aria-hidden="true" d="M0,0h42.28076171875v11h-42.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#228833" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">LMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(149,0)"><path class="background" aria-hidden="true" d="M0,0h31.28076171875v11h-31.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#EE6677" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">AD</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-title"><g transform="translate(250,-47)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Distribution of Disease Stages by Diagnosis, MLE'" pointer-events="none"><text text-anchor="middle" transform="translate(0,1)" font-family="sans-serif" font-size="14px" font-weight="normal" fill="#000" opacity="1">Distribution of Disease Stages by Diagnosis, MLE</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>